Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multifocal choroiditis and panuveitis: immunomodulatory therapy.

Shawkat Shafik Michel1, Anthony Ekong, Stefanos Baltatzis

  • 1Ocular Immunology and Uveitis Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114, USA.

Ophthalmology
|February 5, 2002
PubMed
Summary

Immunomodulatory therapy effectively controls inflammation and preserves vision in patients with multifocal choroiditis and panuveitis (MCP). This treatment is crucial for maintaining visual acuity in affected individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saliva as a noninvasive diagnostic for ocular sarcoidosis.

Journal of leukocyte biology·2026
Same author

Oral cyclophosphamide as part of the treatment regimen in patients with nonparaneoplastic autoimmune retinopathy secondary to birdshot chorioretinopathy.

Oman journal of ophthalmology·2026
Same author

How to interpret low-dose valacyclovir for postherpetic neuralgia in the Zoster Eye Disease Study-a randomized clinical trial.

Annals of translational medicine·2026
Same author

Oral cyclophosphamide monotherapy in advanced resistant ocular cicatricial pemphigoid.

Taiwan journal of ophthalmology·2025
Same author

The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular Hypertension.

Ophthalmology. Glaucoma·2025
Same author

Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis.

Ocular immunology and inflammation·2025

Area of Science:

  • Ophthalmology
  • Immunology
  • Uveitis Management

Background:

  • Multifocal choroiditis and panuveitis (MCP) is a severe inflammatory eye condition.
  • Systemic steroids are a common treatment but carry significant side effects.
  • Long-term steroid use can lead to cataracts and glaucoma.

Observation:

  • A retrospective study analyzed 19 patients with bilateral MCP.
  • Fifteen patients received immunomodulatory therapy; four received only systemic steroids.
  • Patients treated solely with steroids experienced severe complications.

Findings:

  • Immunomodulatory therapy controlled inflammation and preserved vision in MCP patients.
  • Patients on immunomodulatory therapy did not experience vision loss.

Related Experiment Videos

  • Steroid-naive patients who refused immunomodulatory therapy lost significant vision.

    • Implications:

    • Immunomodulatory therapy is a safe and effective treatment for multifocal choroiditis and panuveitis.
    • Early intervention with immunomodulatory therapy can prevent vision loss.
    • This approach offers a better alternative to long-term systemic steroid use.